Vol 60, No 3 (2022)
Original paper
Published online: 2022-08-04

open access

Page views 4426
Article views/downloads 855
Get Citation

Connect on Social Media

Connect on Social Media

Activation of the JAK1/STAT1 signaling pathway is associated with peroxiredoxin 6 expression levels in human epididymis epithelial cells

Hui Shi1, Xiaoyu Liu2, Yanwei Wang3, Haiyan Wang3, Bochen Pan2, Jianyuan Li4
Pubmed: 35929062
Folia Histochem Cytobiol 2022;60(3):226-236.

Abstract

Introduction. Peroxiredoxin 6 (Prdx6) is widely expressed in mammalian tissues. Our previous study demonstrated that Prdx6 was expressed in human epididymis, present in human seminal fluid, and in spermatozoa. The protective role of Prdx6 in maintaining the viability and DNA integrity of human spermatozoa was also detected. Here, we demonstrate the potential role and mechanism of Prdx6 in human epididymis epithelial cells (HEECs).
Material and methods. Western blotting was used to measure expression levels of key proteins in the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway. The malonaldehyde (MDA) levels and antioxidant capacity in HEECs were detected with the commercial kits. Digital gene expression analysis (DGE) was used to identify gene expression patterns in control and Prdx6-interference HEECs. Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to validate the DGE findings.
Results. Compared to control HEECs, the expression levels of JAK1, STAT1, phosphorylated JAK1 and STAT1 were significantly increased, while the expression level of SOCS3 was significantly decreased in Prdx6-interference HEECs. The MDA level and total antioxidant capacity in Prdx6-interference HEECs were significantly increased and decreased compared to that of control, respectively. DGE analysis identified 589 up-regulated and 314 down-regulated genes (including Prdx6) in Prdx6-interference HEECs. Thirteen significantly different pathways were identified between the two groups, with the majority of genes belonging to the CCL, CXCL, IL, and IFIT family of proteins and were related to immunity. In particular, the expression levels of IL6, IL6ST, and eighteen IFN-related genes were significantly increased in Prdx6-interference HEECs compared to control HEECs.
Conclusions. We found that reduced Prdx6 expression induced higher ROS levels in HEECs, which resulted in the activation of the IL-6 receptor and IFNγ expression to induce the JAK1/STAT1 signaling pathway.

Article available in PDF format

View PDF Download PDF file

References

  1. Jin DY, Chae HZ, Rhee SG, et al. Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem. 1997; 272(49): 30952–30961.
  2. Chowdhury I, Mo Y, Gao L, et al. Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element. Free Radic Biol Med. 2009; 46(2): 146–153.
  3. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012; 24(5): 981–990.
  4. O'Leary PC, Terrile M, Bajor M, et al. Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer. Breast Cancer Res. 2014; 16(4): R79.
  5. Li XJ, Xu M, Zhao XQ, et al. Proteomic analysis of synovial fibroblast-like synoviocytes from rheumatoid arthritis. Clin Exp Rheumatol. 2013; 31(4): 552–558.
  6. Moon EY, Noh YW, Han YH, et al. T lymphocytes and dendritic cells are activated by the deletion of peroxiredoxin II (Prx II) gene. Immunol Lett. 2006; 102(2): 184–190.
  7. Szabó-Taylor KÉ, Eggleton P, Turner CAL, et al. Lymphocytes from rheumatoid arthritis patients have elevated levels of intracellular peroxiredoxin 2, and a greater frequency of cells with exofacial peroxiredoxin 2, compared with healthy human lymphocytes. Int J Biochem Cell Biol. 2012; 44(8): 1223–1231.
  8. Huh JY, Kim Y, Jeong J, et al. Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression. Antioxid Redox Signal. 2012; 16(3): 229–243.
  9. Guo X, Yamada S, Tanimoto A, et al. Overexpression of peroxiredoxin 4 attenuates atherosclerosis in apolipoprotein E knockout mice. Antioxid Redox Signal. 2012; 17(10): 1362–1375.
  10. Schulte J. Peroxiredoxin 4: a multifunctional biomarker worthy of further exploration. BMC Med. 2011; 9: 137.
  11. Chang X, Cui Y, Zong M, et al. Identification of proteins with increased expression in rheumatoid arthritis synovial tissues. J Rheumatol. 2009; 36(5): 872–880.
  12. Kropotov A, Usmanova N, Serikov V, et al. Mitochondrial targeting of human peroxiredoxin V protein and regulation of PRDX5 gene expression by nuclear transcription factors controlling biogenesis of mitochondria. FEBS J. 2007; 274(22): 5804–5814.
  13. Park MiH, Jo M, Kim YuRi, et al. Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases. Pharmacol Ther. 2016; 163: 1–23.
  14. Yun HM, Choi DY, Oh KiW, et al. PRDX6 exacerbates dopaminergic neurodegeneration in a MPTP mouse model of parkinson's disease. Mol Neurobiol. 2015; 52(1): 422–431.
  15. Yun HM, Park KR, Kim EC, et al. PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption. Oncotarget. 2015; 6(25): 20875–20884.
  16. Yun HM, Park KR, Park MiH, et al. PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model. Free Radic Biol Med. 2015; 80: 136–144.
  17. Kim DH, Lee DH, Jo MiR, et al. Exacerbation of collagen antibody-induced arthritis in transgenic mice overexpressing peroxiredoxin 6. Arthritis Rheumatol. 2015; 67(11): 3058–3069.
  18. O'Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 2002; 109 Suppl: S121–S131.
  19. Herrera SC, Bach EA. JAK/STAT signaling in stem cells and regeneration: from to vertebrates. Development. 2019; 146(2).
  20. Baker BJ, Akhtar LN, Benveniste EN. SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol. 2009; 30(8): 392–400.
  21. Alston CI, Dix RD. SOCS and herpesviruses, with emphasis on cytomegalovirus retinitis. Front Immunol. 2019; 10: 732.
  22. Fernandez MC, O'Flaherty C. Peroxiredoxin 6 is the primary antioxidant enzyme for the maintenance of viability and DNA integrity in human spermatozoa. Hum Reprod. 2018; 33(8): 1394–1407.
  23. Shi H, Liu J, Zhu P, et al. Expression of peroxiredoxins in the human testis, epididymis and spermatozoa and their role in preventing H2O2-induced damage to spermatozoa. Folia Histochem Cytobiol. 2018; 56(3): 141–150.
  24. Zhou W, De Iuliis GN, Dun MD, et al. Characteristics of the Epididymal Luminal Environment Responsible for Sperm Maturation and Storage. Front Endocrinol (Lausanne). 2018; 9: 59.
  25. Dubé E, Dufresne J, Chan PTK, et al. Assessing the role of claudins in maintaining the integrity of epididymal tight junctions using novel human epididymal cell lines. Biol Reprod. 2010; 82(6): 1119–1128.
  26. Holen T, Amarzguioui M, Wiiger MT, et al. Positional effects of short interfering rnas targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 2002; 30(8): 1757–1766.
  27. 't Hoen PAC, Ariyurek Y, Thygesen HH, et al. Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res. 2008; 36(21): e141.
  28. Morrissy AS, Morin RD, Delaney A, et al. Next-generation tag sequencing for cancer gene expression profiling. Genome Res. 2009; 19(10): 1825–1835.
  29. Audic S, Claverie JM. The significance of digital gene expression profiles. Genome Res. 1997; 7(10): 986–995.
  30. Benjamini Y, Yekutieli D, et al. The control of the false discovery rate in multiple testing under dependency. Ann. Statist. 2001; 29(4): 1165–1188.
  31. Ye J, Fang L, Zheng H, et al. WEGO: a web tool for plotting GO annotations. Nucleic Acids Res. 2006; 34(Web Server issue): W293–W297.
  32. Kanehisa M, Araki M, Goto S, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2008; 36(Database issue): D480–D484.
  33. Leong KP, Tee NW, Yap WM, et al. Nocardiosis in patients with systemic lupus erythematosus. The Singapore Lupus Study Group. J Rheumatol. 2000; 27(5): 1306–1312.
  34. Amoyel M, Anderson AM, Bach EA. JAK/STAT pathway dysregulation in tumors: a Drosophila perspective. Semin Cell Dev Biol. 2014; 28: 96–103.
  35. Kleppe M, Spitzer MH, Li S, et al. Jak1 integrates cytokine sensing to regulate hematopoietic stem cell function and stress hematopoiesis. Cell Stem Cell. 2017; 21(4): 489–501.e7.
  36. Zhao XF, Wan J, Powell C, et al. Leptin and IL-6 family cytokines synergize to stimulate Müller glia reprogramming and retina regeneration. Cell Rep. 2014; 9(1): 272–284.
  37. Dawn B, Xuan YT, Guo Y, et al. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res. 2004; 64(1): 61–71.
  38. Puthier D, Bataille R, Amiot M. IL-6 up-regulates mcl-1 in human myeloma cells through JAK/STAT rather than ras/MAP kinase pathway. Eur J Immunol. 1999; 29(12): 3945–3950, doi: 10.1002/(sici)1521-4141(199912)29:12<3945::aid-immu3945>3.0.co;2-o.
  39. Yadav A, Kumar B, Datta J, et al. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res. 2011; 9(12): 1658–1667.
  40. Chang Q, Bournazou E, Sansone P, et al. The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia. 2013; 15(7): 848–862.
  41. Yamamoto M, Okuyama M, Ma JiSu, et al. A cluster of interferon-γ-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity. 2012; 37(2): 302–313.
  42. Moon JiW, Kong SK, Kim BS, et al. IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma. Sci Rep. 2017; 7(1): 17810.